Calgill Pharma Private Limited
About Calgill Pharma Private Limited
Data last updated:
Calgill Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2019PTC121486. Its GSTIN is 29AAICC0226B1Z6 (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Chaithra and Gonurkoppa Rajappa Ramakrishna.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.6 1st Floor 7th Main 17th Cross N.S Palya Btm Layout 2nd Stage, Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2024, the company reported a revenue of ₹52.02 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹1.26 Lakh (net margin 2.4%) and EBITDA of ₹2.91 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.
Company details
Contact details
Calgill Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo.6 1st Floor 7th Main 17th Cross N.S Palya Btm Layout 2nd Stage, Bangalore, Karnataka, India – 560076
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Calgill Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Calgill Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Calgill Pharma Private Limited, buy the company report.
Financials of Calgill Pharma Private Limited
FY 2024 filings availableCalgill Pharma Private Limited reported revenue of ₹52.02 Lakh (up 43% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 49% over three years, including 43% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Calgill Pharma Private Limited, buy the company report.
Board of directors of Calgill Pharma Private Limited
Calgill Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chaithra | Director | 15 Feb 2020 | 6 Years 8 Months | Current |
| Gonurkoppa Rajappa Ramakrishna | Director | 14 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Calgill Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Marrikind Plus (OPC) Private Limited | ₹52.61 Lakh (FY 2023) | 160.0% | Lucknow, Uttar Pradesh, India | |||
| Cgenic Meditech Private Limited | ₹52.25 Lakh (FY 2025) | 35.0% | Vadodara, Gujarat, India | |||
| Calgill Pharma Private Limitedthis company | ₹52.02 Lakh (FY 2024) | ₹1.26 Lakh | 2.4% | 43.0% | Bangalore, Karnataka, India | |
| Zoriox Innovation Labs Private Limited | ₹51.77 Lakh (FY 2023) | 8.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Calgill Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Calgill Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Calgill Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Calgill Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICC0226B1Z6 | Karnataka | Active | 27 Feb 2019 |
To see the full GST registrations and return filing status of Calgill Pharma Private Limited, buy the company report.
Recent activity
Calgill Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Chaithra was appointed as Director on 15 Feb 2020.
Frequently asked questions
Calgill Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 2019 (7+ years old) and is registered under CIN U24290KA2019PTC121486.
Calgill Pharma has 2 current directors:
- Chaithra - Director
- Gonurkoppa Rajappa Ramakrishna - Director
The latest financial statements of Calgill Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Calgill Pharma is 29AAICC0226B1Z6, registered in Karnataka.
The CIN (Corporate Identification Number) of Calgill Pharma is U24290KA2019PTC121486. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Calgill Pharma was incorporated on 14 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Calgill Pharma by revenue are Marrikind Plus (OPC) Private Limited, Cgenic Meditech Private Limited, Zoriox Innovation Labs Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other hospital and medical care activities).
Chaithra was appointed as Director on 15 Feb 2020. Manishettahalli Chandrappa Suresha ceased to be Director on 15 Feb 2020. Gonurkoppa Rajappa Ramakrishna was appointed as Director on 14 Feb 2019.
The registered office of Calgill Pharma is at No.6 1st Floor 7th Main 17th Cross N.S Palya Btm Layout 2nd Stage, Bangalore, Karnataka, India – 560076.
Calgill Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Calgill Pharma can be reached at its registered office: No.6 1st Floor 7th Main 17th Cross N.S Palya Btm Layout 2nd Stage, Bangalore, Karnataka, India – 560076.